12 Health Care Stocks Moving In Friday's After-Market Session
Adial Pharmaceuticals Inc ADIL
$3.34
▲ +1.52%
(+$0.05)
🎈 Low Float
🗓️ Earnings Next Week
Open
$3.30
Prev Close
$3.29
Day Range
$3.20 – $3.39
52W Range
$1.31 – $293.75
Market Cap
$7.31M
Beta
-670.87
EPS (TTM)
$-9.93
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-07-27 |
| Shares Out. | 2,580,000 |
| Website | adialpharma.com/ ↗ |
| Phone | 14344229800 |
| Employees | 6 |
| Net Income | -$2.0M |
| Total Assets | $5.2M |
| Total Liabilities | $1.5M |
| Equity | $3.7M |
About Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Adial Pharmaceuticals Inc is a publicly traded company under the ticker symbol ADIL on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)